A genetic form of COPD, Alpha-1 deficiency increases the risk of emphysema, asthma, chronic bronchitis, lung infections, and bronchiectasis.1 Alpha-1 is frequently underrecognized or misdiagnosed because its symptoms-shortness, of breath, wheezing, and coughing-resemble those of other chronic lung diseases.2 Left undiagnosed and untreated, Alpha-1 deficiency can cause significant and irreversible lung damage, and, in some cases, death.3
As many as 100,000 people in the United States have Alpha-1 deficiency, but up to 95% of those are undiagnosed.2 In one study of patients who were tested, Alpha-1 deficiency has been
detected in 3.1% of individuals with chronic bronchitis, emphysema, asthma, or a family history of Alpha-1 (n=16,748).3
Without question, increased testing of Alpha-1 is needed to ensure that more patients are correctly diagnosed and treated earlier. The American Thoracic Society (ATS) recommends screening all COPD patients [link to Who is at risk] for Alpha-1 deficiency.
Don't let Alpha-1 deficiency go undiagnosed. Test today.